Main Menu

Professor Alan Melcher

Team Leader

The alt text
Professor Melcher is a clinician scientist studying how to activate the immune system to recognise and attack cancer. In particular, he works on oncolytic, anti-cancer viruses, which work mainly as a type of immunotherapy, and is a specialist in melanoma and head and neck cancer. Team: Translational Immunotherapy
020 7153 5205 ORCID 0000-0002-2042-3380


Professor Alan Melcher graduated in medicine from the University of Oxford in 1989, and trained in Clinical Oncology (Radiotherapy and Chemotherapy) in Cardiff, London and Leeds.

See all news stories on our website that feature the work of Professor Melcher and colleagues.

Read news

Following completion of his PhD at the Imperial Cancer Research Fund (now Cancer Research UK) in London, he was a post-doctoral research fellow at the Mayo Clinic, Minnesota, before returning to the UK, where he became Professor of Clinical Oncology and Biotherapy in Leeds in 2007.

In April 2016, he moved to The Institute of Cancer Research, London, as Professor of Translational Immunology and Honorary Consultant Oncologist at The Royal Marsden NHS Foundation Trust. He combines a clinical practice in head and neck cancer and melanoma with laboratory and translational research focused on oncolytic viruses and immunotherapy for the treatment of cancer.